Par Pharma Begins Shipping Generic Atacand HCT
December 05, 2012 at 17:08 PM EST
Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive U.S. supply and distribution agreement with AstraZeneca (NYSE: AZN ) to distribute the authorized generic version of AstraZeneca's Atacand HCT^® (candesartan cilexetil/hydrochlorothiazide). Par has begun shipping 16/12.5 mg, 32/12.5 mg and 32/25 mg strengths of candesartan cilexetil/